Similar articles

• [The overlap syndrome of autoimmune hepatitis and primary biliary cirrhosis. Clinical and therapeutic analysis of 5 cases].

  Cheikh I, Said Y, Chaabouni H, Ouerghi H, Ben Ammar A. Cheikh I, et al. Tunis Med. 2003 Jul;81(7):499-504. Tunis Med. 2003. PMID: 14534962 French.
• Triple therapy with ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: a 1-year randomized, placebo-controlled study.

  Wolfhagen FH, van Hoogstraten HJ, van Buuren HR, van Berge-Henegouwen GP, ten Kate FJ, Hop WC, van der Hoek EW, Kerbert MJ, van Lijf HH, den Ouden JW, Smit AM, de Vries RA, van Zanten RA, Schalm SW. Wolfhagen FH, et al. J Hepatol. 1998 Nov;29(5):736-42. doi: 10.1016/s0168-8278(98)80254-7. J Hepatol. 1998. PMID: 9833911 Clinical Trial.
• Ursodeoxycholic acid and primary biliary cirrhosis with features of autoimmune hepatitis.

  Chazouillères O, Poupon R. Chazouillères O, et al. Hepatology. 2002 Oct;36(4 Pt 1):1026-7; author reply 1027. doi: 10.1053/jhep.2002.34853. Hepatology. 2002. PMID: 12297861 No abstract available.
• Autoimmune liver disease. Current standards, future directions.

  Gish RG, Mason A. Gish RG, et al. Clin Liver Dis. 2001 May;5(2):287-314. doi: 10.1016/s1089-3261(05)70167-7. Clin Liver Dis. 2001. PMID: 11385965 Review.
• [Autoimmune liver disease: diagnosis and therapy].

  Bayer EM, Schramm C, Kanzler S, Lohse AW. Bayer EM, et al. Z Gastroenterol. 2004 Jan;42(1):19-30. doi: 10.1055/s-2004-812686. Z Gastroenterol. 2004. PMID: 14997400 Review. German.